RSV replication inhibitors (Georgia State University/Aviragen)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameRSV replication inhibitors (Georgia State University/Aviragen)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGeorgia State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVaxart Biosciences IncGeorgia State UniversityVaxart Inc
Active IndicationsN/A
Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A